8-K Announcements
6Material company update
May 29, 2026·SEC
Material company update
May 21, 2026·SEC
Material company update
May 21, 2026·SEC
Wellgistics Health, Inc.(WGRX)Earnings, Financials & Key Ratios
WGRX•NASDAQ
Price updated Jun 19, 2026
AboutWellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.Show more
- Revenue$23M+28.7%
- EBITDA-$78M-1450.2%
- Net Income-$101M-1377.1%
- EPS (Diluted)-71.50-1000.0%
- Gross Margin-41.3%-523.6%
- EBITDA Margin-334.15%-1104.2%
- Operating Margin-347.91%-926.4%
- Net Margin-433.95%-1047.4%
WGRX Key Insights
Wellgistics Health, Inc. (WGRX) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
No significant strengths identified
✗Weaknesses
- ✗Weak Piotroski F-Score: 2/9
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 2 (bottom 2%)
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Shares diluted 36.7% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when WGRX posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
WGRX Price & Volume
Wellgistics Health, Inc. (WGRX) stock price & volume — 10-year historical chart
Loading chart...
WGRX Growth Metrics
Wellgistics Health, Inc. (WGRX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-33.34%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-104.16%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-21.27%
Return on Capital
10 Years-443.4%
5 Years-443.4%
3 Years-443.4%
Last Year-813.36%
WGRX Recent Earnings
Wellgistics Health, Inc. (WGRX) EPS & revenue vs analyst estimates — last 4 quarters
Q2 2026Latest
May 19, 2026Metric
Actual
Est
EPS
$0.07
—
Rev
$2M
—
Q2 2026
Mar 20, 2026Metric
Actual
Est
EPS
$0.13
—
Rev
$2M
—
Q4 2025
Nov 19, 2025Metric
Actual
Est
EPS
$0.44
—
Rev
$3M
—
Q3 2025
Aug 19, 2025Metric
Actual
Est
EPS
$0.11
—
Rev
$8M
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 19, 2026 | $0.07 | $2M |
| Q2 2026 | Mar 20, 2026 | $0.13 | $2M |
| Q4 2025 | Nov 19, 2025 | $0.44 | $3M |
| Q3 2025 | Aug 19, 2025 | $0.11 | $8M |
Based on last 5 quarters of dataView full earnings history →
WGRX Peer Comparison
Wellgistics Health, Inc. (WGRX) competitors in Drug Wholesalers and Distributors — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 HSIC | 9.17B | 79.92 | 24.44 | 4.03% | 3.02% | 8.24% | 0.77 | |
 OMI | 171.11M | 2.24 | -0.16 | -74.19% | -39.85% | -21.12% | ||
 HCSG | 1.64B | 22.94 | 28.32 | 7.08% | 3.21% | 11.83% | 0.05 | |
 MCK | 90.23B | 750.63 | 19.56 | 12.36% | 1.18% | |||
 CAH | 52.19B | 221.77 | 34.38 | -1.87% | 0.62% | |||
 PAHC | 1.29B | 31.85 | 26.76 | 27.37% | 6.29% | 30.81% | 2.67 | |
 RDNT | 4.23B | 53.74 | -214.96 | 11.51% | -0.66% | -1.09% | 1.37 | |
 CVS | 125.45B | 98.32 | 70.73 | 7.85% | 0.72% | 3.86% | 1.24 |
Compare WGRX vs Peers
Wellgistics Health, Inc. (WGRX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
WGRX Income Statement
Wellgistics Health, Inc. (WGRX) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|
Sales/Revenue | 0 | 18.13M | 23.34M | 14.03M |
Revenue Growth % | - | - | 28.73% | -33.34% |
Cost of Goods Sold | 0 | 16.36M | 32.98M | 24.55M |
COGS % of Revenue | - | 90.25% | 141.3% | - |
Gross Profit | 0▲ 0% | 1.77M▲ 0% | -9.64M▼ 645.3% | -10.52M▲ 0% |
Gross Margin % | - | 9.75% | -41.3% | -74.94% |
Gross Profit Growth % | - | - | -645.32% | - |
Operating Expenses | 2.88M | 7.91M | 71.56M | 45.35M |
OpEx % of Revenue | - | 43.65% | 306.61% | - |
Selling, General & Admin | 2.88M | 6.8M | 71.56M | 46.15M |
SG&A % of Revenue | - | 37.5% | 306.61% | - |
Research & Development | 375 | 0 | 0 | 0 |
R&D % of Revenue | - | - | - | - |
Other Operating Expenses | -375 | 1.11M | 0 | 605.59K |
Operating Income | -2.88M▲ 0% | -6.15M▼ 113.3% | -81.19M▼ 1221.3% | -55.86M▲ 0% |
Operating Margin % | - | -33.9% | -347.91% | -398.05% |
Operating Income Growth % | - | -113.33% | -1221.29% | - |
EBITDA | -2.88M | -5.03M | -77.98M | -53.1M |
EBITDA Margin % | - | -27.75% | -334.15% | -378.35% |
EBITDA Growth % | - | -74.63% | -1450.23% | -68.47% |
D&A (Non-Cash Add-back) | 0 | 1.11M | 3.21M | 2.77M |
EBIT | -2.88M | -6.02M | -81.19M | -55.87M |
Net Interest Income | -15.08K | -831.47K | -4.58M | -1.41M |
Interest Income | 0 | 0 | 0 | 0 |
Interest Expense | 15.08K | 831.47K | 4.58M | 1.41M |
Other Income/Expense | -15.08K | -711.09K | -20.08M | -20.72M |
Pretax Income | -2.9M▲ 0% | -6.86M▼ 136.8% | -101.27M▼ 1377.1% | -76.59M▲ 0% |
Pretax Margin % | - | -37.82% | -433.95% | -545.72% |
Income Tax | 0 | 0 | 0 | 0 |
Effective Tax Rate % | 0% | 0% | 0% | 0% |
Net Income | -2.9M▲ 0% | -6.86M▼ 136.8% | -101.27M▼ 1377.1% | -76.59M▲ 0% |
Net Margin % | - | -37.82% | -433.95% | -545.72% |
Net Income Growth % | - | -136.77% | -1377.12% | -104.16% |
Net Income (Continuing) | -2.9M | -6.86M | -101.27M | -76.59M |
Discontinued Operations | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 |
EPS (Diluted) | -3.00▲ 0% | -6.50▼ 116.7% | -71.50▼ 1000.0% | -53.94▲ 0% |
EPS Growth % | - | -116.67% | -1000% | -21.27% |
EPS (Basic) | -3.00 | -6.50 | -71.50 | - |
Diluted Shares Outstanding | 894.4K | 1.04M | 1.42M | 1.42M |
Basic Shares Outstanding | 894.4K | 1.04M | 1.42M | 1.42M |
Dividend Payout Ratio | - | - | - | - |
WGRX Balance Sheet
Wellgistics Health, Inc. (WGRX) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|
Total Current Assets | 338.36K | 15.17M | 2.82M | 2.76M |
Cash & Short-Term Investments | 1.36K | 1.03M | 42.57K | 51.73K |
Cash Only | 1.36K | 1.03M | 42.57K | 51.73K |
Short-Term Investments | 0 | 0 | 0 | 0 |
Accounts Receivable | 337K | 3.75M | 1.14M | 992.15K |
Days Sales Outstanding | - | 75.42 | 17.79 | 46.96 |
Inventory | 0 | 9.52M | 1.64M | 1.71M |
Days Inventory Outstanding | - | 212.35 | 18.15 | 73.88 |
Other Current Assets | 0 | 875.39K | 0 | 4.2K |
Total Non-Current Assets | 0 | 42.16M | 27.64M | 27.37M |
Property, Plant & Equipment | 0 | 1.92M | 1.2M | 1.05M |
Fixed Asset Turnover | - | 9.46x | 19.51x | 10.96x |
Goodwill | 0 | 16.22M | 14.19M | 14.19M |
Intangible Assets | 0 | 22.36M | 10.31M | 9.99M |
Long-Term Investments | 0 | 17.67K | 0 | 279.54K |
Other Non-Current Assets | 0 | 1.65M | 1.94M | 2.14M |
Total Assets | 338.36K▲ 0% | 57.33M▲ 16844.1% | 30.46M▼ 46.9% | 30.13M▲ 0% |
Asset Turnover | - | 0.32x | 0.77x | 0.33x |
Asset Growth % | - | 16844.08% | -46.87% | -78.58% |
Total Current Liabilities | 2.89M | 38.05M | 29.78M | 32.2M |
Accounts Payable | 1.04M | 6.33M | 11.69M | 12M |
Days Payables Outstanding | - | 141.31 | 129.4 | 162.07 |
Short-Term Debt | 350K | 12.04M | 11.07M | 15.35M |
Deferred Revenue (Current) | 0 | 245.76K | 488.23K | 815.99K |
Other Current Liabilities | 950K | 3.11M | 4.59M | 2.71M |
Current Ratio | 0.12x | 0.40x | 0.09x | 0.09x |
Quick Ratio | 0.12x | 0.15x | 0.04x | 0.03x |
Cash Conversion Cycle | - | 146.46 | -93.47 | -41.24 |
Total Non-Current Liabilities | 350K | 12.55M | 13.13M | 12.99M |
Long-Term Debt | 350K | 11.46M | 13.13M | 12.99M |
Capital Lease Obligations | 0 | 1.1M | 0 | 816.22K |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 |
Total Liabilities | 3.24M | 50.6M | 42.91M | 45.19M |
Total Debt | 700K | 25.11M | 24.77M | 28.91M |
Net Debt | 698.64K | 24.08M | 24.73M | 28.86M |
Debt / Equity | - | 3.73x | - | -1.92x |
Debt / EBITDA | - | - | - | -0.54x |
Net Debt / EBITDA | - | - | - | -0.54x |
Interest Coverage | -191.01x | -7.25x | -17.73x | -39.56x |
Total Equity | -2.9M▲ 0% | 6.73M▲ 332.2% | -12.45M▼ 284.8% | -15.06M▲ 0% |
Equity Growth % | - | 332.19% | -284.84% | -559.66% |
Book Value per Share | -3.24 | 6.48 | -8.77 | -10.61 |
Total Shareholders' Equity | -2.9M | 6.73M | -12.45M | -15.06M |
Common Stock | 4.47K | 5.11K | 10.13K | 11.94K |
Retained Earnings | -2.9M | -9.76M | -111.03M | -118.77M |
Treasury Stock | 0 | 0 | 0 | 0 |
Accumulated OCI | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 |
WGRX Cash Flow Statement
Wellgistics Health, Inc. (WGRX) cash flow — operating, investing & free cash flow history
| Metric | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|
Cash from Operations | -349.14K | -1.22M | -10.86M | -12.92M |
Operating CF Margin % | - | -6.76% | -46.51% | - |
Operating CF Growth % | - | -250.86% | -786.13% | -3248.7% |
Net Income | -2.9M | -6.86M | -101.27M | -76.59M |
Depreciation & Amortization | 0 | 1.11M | 192.22K | 3.92M |
Stock-Based Compensation | 0 | 1.08M | 54.79M | 28.38M |
Deferred Taxes | 0 | 0 | 0 | 0 |
Other Non-Cash Items | 0 | 93.38K | 26.95M | 23.99M |
Working Capital Changes | 2.55M | 3.34M | 8.48M | 7.37M |
Change in Receivables | -269.21K | -40.08K | 799.77K | 1.03M |
Change in Inventory | 0 | -72.36K | 1.89M | 2.03M |
Change in Payables | 1.03M | -882.32K | 2.2M | 1.79M |
Cash from Investing | 0 | 469.07K | -881.53K | -813.49K |
Capital Expenditures | 0 | -377.29K | -881.53K | -187.35K |
CapEx % of Revenue | - | 2.08% | 3.78% | 1.33% |
Acquisitions | 0 | 931.37K | 0 | 0 |
Investments | - | - | - | - |
Other Investing | 0 | -85.01K | 0 | -626.14K |
Cash from Financing | 350.5K | 1.78M | 10.75M | 11.27M |
Debt Issued (Net) | 350K | 620.7K | -2.11M | 1.08M |
Equity Issued (Net) | 500 | 10K | 12.86M | 7.11M |
Dividends Paid | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 |
Other Financing | 0 | 1.15M | 0 | 3.08M |
Net Change in Cash | 1.36K▲ 0% | 1.03M▲ 75191.2% | -985.76K▼ 196.0% | -2.46M▲ 0% |
Free Cash Flow | -349.14K▲ 0% | -1.6M▼ 358.9% | -10.86M▼ 577.5% | -12.9M▲ 0% |
FCF Margin % | - | -8.84% | -46.51% | -91.94% |
FCF Growth % | - | -358.93% | -577.47% | -302.42% |
FCF per Share | -0.39 | -1.54 | -7.65 | -9.09 |
FCF Conversion (FCF/Net Income) | 0.12x | 0.18x | 0.11x | 0.17x |
Interest Paid | 0 | 0 | 0 | -616.07K |
Taxes Paid | 0 | 0 | 0 | 0 |
WGRX Key Ratios
Wellgistics Health, Inc. (WGRX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2024 | 2025 | TTM |
|---|---|---|---|
Return on Equity (ROE) | -357.65% | - | 1545.09% |
Return on Invested Capital (ROIC) | -32.21% | -282.63% | -209.03% |
Gross Margin | 9.75% | -41.3% | -74.94% |
Net Margin | -37.82% | -433.95% | -545.72% |
Debt / Equity | 3.73x | - | -1.92x |
Interest Coverage | -7.25x | -17.73x | -39.56x |
FCF Conversion | 0.18x | 0.11x | 0.17x |
Revenue Growth | - | 28.73% | -33.34% |
Related:WGRX Dividend History·WGRX Revenue History·WGRX Price History·WGRX P/E History·WGRX Financial Ratios·WGRX Institutional Holders
WGRX SEC Filings & Documents
Wellgistics Health, Inc. (WGRX) SEC filings — annual & quarterly reports (10-K, 10-Q)
WGRX Frequently Asked Questions
Wellgistics Health, Inc. (WGRX) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Wellgistics Health, Inc. (WGRX) reported $14.0M in revenue for fiscal year 2025.
Wellgistics Health, Inc. (WGRX) grew revenue by 28.7% over the past year. This is strong growth.
Wellgistics Health, Inc. (WGRX) reported a net loss of $76.6M for fiscal year 2025.
Dividend & Returns
Wellgistics Health, Inc. (WGRX) had negative free cash flow of $12.9M in fiscal year 2025, likely due to heavy capital investments.